DEFINITIVE PROXY STATEMENT

Company

Protara Therapeutics, Inc.

Filed

April 26, 2018

Period of Report

June 8, 2018

Accession Number

0001171843-18-003107

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →